BIOPSY BREAST MRM WITH ER PR HER2
- Report in 4 days
- Tissue
₹6,500
Price
₹6,000
or call 77900 98009
ALK 1 (IHC Marker)
₹6,000
The ALK-1 IHC test uses immunohistochemistry on a tissue biopsy to detect anaplastic lymphoma kinase (ALK) protein, produced when the ALK gene is rearranged.
ALK positivity helps diagnose ALK-positive anaplastic large cell lymphoma (ALCL), which has a better prognosis than ALK-negative ALCL. It also identifies inflammatory myofibroblastic tumors, rare ALK-positive B-cell lymphomas, and some lung cancers, though lung testing often uses more sensitive clones.
A positive result can guide treatment with ALK inhibitors such as crizotinib, alectinib, or lorlatinib, and helps classify tumors accurately.
An ALK-1 IHC test is advised by a pathologist or oncologist when a biopsy shows lymphoma, especially suspected anaplastic large cell lymphoma, or a tumor of uncertain type such as an inflammatory myofibroblastic tumor. It is also used for some lung cancers, to help decide whether ALK-targeted therapy may be suitable.
An ALK-1 IHC test is performed on a tissue biopsy, usually from an existing paraffin block, so no special preparation or fasting is needed. Submit the paraffin blocks or slides along with the histopathology report. If a new biopsy is required, follow your doctor’s instructions, including stopping blood thinners or fasting if sedation is planned.
No, fasting is not required for an ALK-1 IHC test, as it is usually performed on an existing biopsy tissue block. However, if a new biopsy is needed to obtain tissue, you may need to fast if sedation is planned. Follow your doctor’s specific instructions.
₹6,500
₹1,500
₹5,000
₹3,500
Tell us what your doctor has prescribed and our team will confirm the right test and book it for you.